ES2059471T3 - Un procedimiento para preparar un derivado de rodamina. - Google Patents

Un procedimiento para preparar un derivado de rodamina.

Info

Publication number
ES2059471T3
ES2059471T3 ES88118796T ES88118796T ES2059471T3 ES 2059471 T3 ES2059471 T3 ES 2059471T3 ES 88118796 T ES88118796 T ES 88118796T ES 88118796 T ES88118796 T ES 88118796T ES 2059471 T3 ES2059471 T3 ES 2059471T3
Authority
ES
Spain
Prior art keywords
substituted
rodamine
derivative
preparing
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88118796T
Other languages
English (en)
Inventor
Hitoshi Inoue
Hiroyasu Koyama
Reiko Kubota
Hirohiko Komatsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Seifun Group Inc
Original Assignee
Nisshin Seifun Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Seifun Group Inc filed Critical Nisshin Seifun Group Inc
Application granted granted Critical
Publication of ES2059471T3 publication Critical patent/ES2059471T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

COMPUESTO DE FORMULA: (FORMULA) SON REVELADOS, DONDE R1 ES UN ALQUIL C1-C6 O UN GRUPO -(CH2)NCOOR3 EN EL CUAL N ES UN ENTERO ENTRE 1 A 4 Y R3 ES HIDROGENO O UN ALQUIL C1-C6, Y R2 ES UN GRUPO -CH=CH-R4 O -CH2-CH2-R4 EN EL CUAL R4 ES UN FENIL SUSTITUIDO O NO SUSTITUIDO, O UN GRUPO HETEROCICLICO DE 5 MIEMBROS SUSTITUIDO O NO SUSTITUIDO O SALES FARMACEUTICAMENTE ACEPTABLES DE ELLO, LAS COMPOSICIONES FARMACEUTICAS COMPRENDEN LA MISMA COMO INGREDIENTE ACTIVO, SU USO PARA LA PREPARACION DE MEDICAMENTOS ASI COMO UN PROCESO PARA SU PREPARACION. LOS COMPONENTES TIENEN UNA EXCELENTE ACTIVIDAD INHIBITONIA DE MEDIADORA QUIMICA.
ES88118796T 1987-11-13 1988-11-11 Un procedimiento para preparar un derivado de rodamina. Expired - Lifetime ES2059471T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28899887 1987-11-13

Publications (1)

Publication Number Publication Date
ES2059471T3 true ES2059471T3 (es) 1994-11-16

Family

ID=17737522

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88118796T Expired - Lifetime ES2059471T3 (es) 1987-11-13 1988-11-11 Un procedimiento para preparar un derivado de rodamina.

Country Status (6)

Country Link
US (1) US4897406A (es)
EP (1) EP0316790B1 (es)
KR (1) KR960009424B1 (es)
CA (1) CA1336837C (es)
DE (1) DE3883164T2 (es)
ES (1) ES2059471T3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933355A (en) * 1988-04-14 1990-06-12 Sankyo Company Limited Thiazole derivatives, their preparation and their use in the treatment of diabetes complications
US5116855A (en) * 1989-05-19 1992-05-26 Nisshin Flour Milling Co., Ltd. Rhodanine derivatives and pharmaceutical compositions
KR19980701588A (ko) * 1995-01-23 1998-05-15 피터 쥐. 스트링거 다발성 경화증의 치료 방법(Method for Treating Multiple Sclerosis)
WO2000018746A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders
AU6330999A (en) * 1998-09-30 2000-04-17 Roche Diagnostics Gmbh Rhodanine derivatives for the treatment and prevention of metabolic bone disorders
WO2009142720A1 (en) * 2008-05-19 2009-11-26 Microbiotix, Inc. Inhibitors of bacterial biofilm formation
FR2965730B1 (fr) 2010-10-08 2013-03-29 Oreal Utilisation de derives de methoxyalcoxyphenyl-alkyle substitues comme conservateur, procede de conservation, composes et composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1604530A (es) * 1967-06-06 1971-11-29
JPS5740478A (en) * 1980-08-22 1982-03-06 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative
US4791126A (en) * 1980-08-22 1988-12-13 Ono Pharmaceutical Co., Ltd. Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredients
ES8602712A1 (es) * 1983-11-29 1985-12-01 Kaken Pharma Co Ltd Un procedimiento para preparar un derivado de rodanina
HU210339B (en) * 1985-05-21 1995-03-28 Pfizer Process for preparing thiazolidinediones and their pharmaceutical compositions haring hypoglycemic effect
JPS6212776A (ja) * 1985-07-10 1987-01-21 Taiho Yakuhin Kogyo Kk ロ−ダニン誘導体
JPS6229570A (ja) * 1985-07-29 1987-02-07 Kanegafuchi Chem Ind Co Ltd ３，５−ジイソプロピルベンジリデン複素環式化合物
PT83152B (pt) * 1985-08-09 1989-03-30 Lilly Co Eli Processo para a preparacao de compostos di-t-butilfenoicos

Also Published As

Publication number Publication date
EP0316790B1 (en) 1993-08-11
US4897406A (en) 1990-01-30
EP0316790A1 (en) 1989-05-24
DE3883164D1 (de) 1993-09-16
KR890008121A (ko) 1989-07-08
DE3883164T2 (de) 1993-12-02
CA1336837C (en) 1995-08-29
KR960009424B1 (en) 1996-07-19

Similar Documents

Publication Publication Date Title
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
MXPA02003199A (es) Derivados de sulfonamida farmaceuticamente activos.
YU21803A (sh) Farmaceutski aktivni derivati sulfonamida koji imaju i lipofilne i jonizujuće osobine kao inhibitori protein-junkinaza
FR2669336B1 (fr) Nouveaux derives d'oxazolo pyridines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
ES2061848T3 (es) Compuestos triciclos, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden.
FI890689A (fi) 3-alkenyl-1-azabicyklo-/3.2.0/ -hept-2-en-2-karboxylsyrafoereningar.
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
ES2066781T3 (es) Nuevas n-(1-alquil-3-hidroxi-4-piperidinil)-benzamidas sustituidas.
NO301542B1 (no) Nye pyrazin-derivater
ES2038630T3 (es) Un procedimiento para preparar un compuesto de acido fenoxiacetico.
DE3882679T2 (de) Kardiovaskulaer aktive verbindungen.
ES2059471T3 (es) Un procedimiento para preparar un derivado de rodamina.
IL148875A0 (en) Sulfonyl hydrazide derivatives, their preparation and pharmaceutical compositions containing them
AR031074A1 (es) Una composicion farmaceutica que comprende un derivado de benzamida como ingrediente activo
ATE48994T1 (de) Benzimidazol-derivat, verfahren zu seiner herstellung und pharmazeutische zusammensetzung.
ES2037758T3 (es) Un metodo de uso de un derivado quinolincarboxilico y su procedimiento de preparacion.
JPS6431727A (en) Dissolution of argininamide and drug composition containing argininamides
EA200100725A2 (ru) Новые бензотиадиазиновые соединения, способ их получения и их содержащие фармацевтические композиции
ES2053652T3 (es) N-(alquilideno sustituido)-1,2,3,4,-tetrahidro-9-acridinaminas, un procedimiento para su preparacion y su uso como medicamentos.
EA200101204A1 (ru) Новые бициклические соединения аминопиразинона, способ их получения и содержащие их фармацевтические композиции
JPS6466116A (en) Antiemetic containing specific substituted phenylalkylamino and amino acid derivatives and compound selected from other serotonin drying drugs
NO833529L (no) Fremgangsmaate for fremstilling av terapeutisk aktive alfa-aryl-alfa-pyridylalkansyrederivater
PT99091A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados da triazina e da pirimidina, como ingredientes activos, destinadas a reverter a resistencia aos agentes anticancerosos e antimalaricos
MX9305578A (es) Adsorbato a base de una mezcla de sustancias auxiliares y un principio activo no solido para la produccion de preparados medicamentosos.
DE3882677D1 (de) Kardiovaskulaer aktive verbindungen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 316790

Country of ref document: ES